First Time Loading...

FibroGen Inc
NASDAQ:FGEN

Watchlist Manager
FibroGen Inc Logo
FibroGen Inc
NASDAQ:FGEN
Watchlist
Price: 1.2 USD Market Closed
Updated: May 22, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement
|
Revenue Breakdown

Balance Sheet

365.9m
-14%
Assets
Growth Rates:
1 Year
-32%
3 Years
-54%
5 Years
-55%
7 Years
-17%
10 Years
+29%
594m
-5%
Liabilities
Growth Rates:
1 Year
+1%
3 Years
+43%
5 Years
+84%
7 Years
+92%
10 Years
+171%
-228.1m
-12%
Equity
Growth Rates:
1 Year
-367%
3 Years
-
5 Years
-
7 Years
-
10 Years
-

Balance Sheet Decomposition
FibroGen Inc

365.9m
Assets
594m
Liabilities
365.9m
Assets
594m
Liabilities
Current Assets 278.2m
Cash & Short-Term Investments 184.7m
Receivables 58.5m
Other Current Assets 35m
Non-Current Assets 87.7m
Long-Term Investments 5.8m
PP&E 76.9m
Other Non-Current Assets 5m
Current Liabilities 196.7m
Accounts Payable 4.4m
Accrued Liabilities 179.5m
Other Current Liabilities 12.9m
Non-Current Liabilities 397.3m
Long-Term Debt 89.7m
Other Non-Current Liabilities 307.6m

Balance Sheet
FibroGen Inc

Rotate your device to view
Balance Sheet
Currency: USD
Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
166
153
174
674
89
126
678
171
156
114
Cash
152
76
79
104
39
41
88
111
136
63
Cash Equivalents
14
78
95
570
51
86
590
60
20
50
Short-Term Investments
14
28
79
62
532
408
8
234
266
122
Total Receivables
14
15
10
9
64
154
42
25
16
41
Accounts Receivables
14
11
6
4
17
159
46
36
28
19
Other Receivables
0
4
4
4
47
5
4
11
12
22
Inventory
0
0
0
0
0
7
17
31
40
42
Other Current Assets
5
4
3
5
5
8
10
13
14
13
Total Current Assets
198
201
267
749
690
703
755
474
493
332
PP&E Net
132
129
124
130
127
84
65
120
101
81
PP&E Gross
0
129
124
130
127
84
65
120
101
81
Accumulated Depreciation
0
48
54
60
65
112
134
132
153
174
Long-Term Investments
144
132
71
11
56
61
3
172
9
5
Other Long-Term Assets
9
9
8
10
8
10
4
8
7
5
Total Assets
484
N/A
471
-3%
470
0%
899
+91%
881
-2%
857
-3%
827
-4%
774
-6%
610
-21%
424
-31%
Liabilities
Accounts Payable
5
7
6
6
9
6
25
26
31
18
Accrued Liabilities
47
48
51
64
66
84
104
180
230
187
Short-Term Debt
0
0
0
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
0
0
0
0
0
12
12
0
0
0
Other Current Liabilities
12
13
8
17
14
1
22
19
13
13
Total Current Liabilities
63
67
65
86
89
103
163
226
274
218
Long-Term Debt
113
112
112
115
114
56
44
18
17
90
Deferred Income Tax
0
0
0
0
0
0
9
9
0
0
Minority Interest
19
19
19
19
19
19
19
20
20
42
Other Liabilities
67
94
117
150
149
164
169
292
321
278
Total Liabilities
262
N/A
293
+12%
314
+7%
370
+18%
371
+0%
341
-8%
405
+19%
565
+40%
632
+12%
628
-1%
Equity
Common Stock
1
1
1
1
1
1
1
1
1
1
Retained Earnings
322
408
470
631
716
785
974
1 264
1 558
1 842
Additional Paid In Capital
546
587
626
1 160
1 227
1 301
1 400
1 476
1 541
1 644
Other Equity
3
2
1
2
2
1
5
4
6
7
Total Equity
221
N/A
178
-20%
156
-12%
529
+239%
509
-4%
516
+1%
422
-18%
209
-50%
21
N/A
204
-854%
Total Liabilities & Equity
484
N/A
471
-3%
470
0%
899
+91%
881
-2%
857
-3%
827
-4%
774
-6%
610
-21%
424
-31%
Shares Outstanding
Common Shares Outstanding
59
62
64
83
85
88
91
93
94
99

See Also

Summary
FGEN intrinsic value, competitors valuation, and company profile.
DCF Valuation
FGEN stock valuation using Discount Cash Flow valuation method.
Relative Valuation
FGEN stock valuation using valuation multiples.
Wall Street Estimates
FGEN price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
FGEN stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 139,400+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.